Filtered By:
Condition: Patent Foramen Ovale
Procedure: Cardiac Catheterization

This page shows you your search results in order of date.

Order by Relevance | Date

Total 19 results found since Jan 2013.

Embolic stroke of undetermined source and patent foramen ovale closure: Practice insights from meta ‐analysis?
Key Points Closure of patent foramen ovale (PFO) in embolic stroke of undetermined source (ESUS) reduces recurrent stroke compared with antiplatelet therapy in select patients but increases risk of atrial fibrillation. Device closure is an attractive option for young patients with an anatomically higher risk PFO and imaging proven ESUS. Benefit of PFO closure in ESUS compared with oral anticoagulation remains undefined.
Source: Catheterization and Cardiovascular Interventions - November 26, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Arka Chatterjee, William B. Hillegass Tags: Valvular and Structural Heart Diseases Source Type: research

Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient ‐years of follow up
ConclusionThe Occlutech device appears to be safe at long ‐term FU with a very low annual cerebrovascular event rate and a low moderate to large shunt rate at 1‐year FU.
Source: Catheterization and Cardiovascular Interventions - November 20, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Roel J. R. Snijder, Laura E. Renes, Maarten Jan Suttorp, Jurrien M. ten Berg, Martijn C. Post Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Clinical Use of the Amplatzer Device in the Management of Intracardiac Defects: A Single-Center Experience
Int J Angiol DOI: 10.1055/s-0038-1626718Device therapy is a viable alternative to open heart surgery in the management of intracardiac defects. The Amplatzer septal occluder (ASO) is one such device that has been adapted to close a wide variety of cardiac defects with few complications and a high success rate. This is a retrospective review of all the patients who received the ASO between 2012 and 2016 at the University of Kentucky. In total, 169 patients underwent percutaneous closure of a septal defect with Amplatzer during the timeframe studied, and of those, 91% received the device for an atrial septal defect or patent...
Source: International Journal of Angiology - January 30, 2018 Category: Cardiology Authors: Rao, Seema S. Scaff, Tyler L. Gurley, John Saha, Sibu Tags: Original Article Source Type: research

Transcatheter closure of patent foramen ovale for secondary prevention of ischemic stroke: Quantitative synthesis of pooled randomized trial data
ConclusionsBased on the results of this analysis of randomized trial data, percutaneous PFO closure appears to be a safe and effective therapeutic option for the secondary prevention of ischemic stroke in patients with PFO and cryptogenic stroke.
Source: Catheterization and Cardiovascular Interventions - January 14, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Abdul Hakeem, Mehmet Cilingiroglu, Angelos Katramados, Konstantinos Dean Boudoulas, Cezar Iliescu, Betul Gundogdu, Konstantinos Marmagkiolis Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Interventional closure of patent foramen ovale with Nit ‐occlud® device in prevention of recurrent neurologic events—Long‐term results
ConclusionsThe Nit‐Occlud PFO device and its delivery system are safe and provides sufficient closure of PFO in patients who suffered from cryptogenic stroke, TIA or paradoxical peripheral embolism. It is associated with high procedural success and favorable rates of complete closure.
Source: Catheterization and Cardiovascular Interventions - October 25, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Aleksander Araszkiewicz, Sylwia S ławek, Olga Trojnarska, Maciej Lesiak, Marek Grygier Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Searching for patent foramen ovale in a 44-year-old female patient after ischemic stroke - diagnostic problems.
We present the case of a 44-year-old female patient after ischemic stroke, in whom PFO was not detected by echocardiography; the defect was ultimately diagnosed by right heart catheterization. PMID: 27516797 [PubMed]
Source: Polish Journal of Cardio-Thoracic Surgery - August 16, 2016 Category: Cardiovascular & Thoracic Surgery Tags: Kardiochir Torakochirurgia Pol Source Type: research

Long ‐term follow‐up after PFO device closure
ConclusionsDevice closure of PFO can be performed safely with very good long‐term resolution of atrial shunting. Recurrent neurologic events after PFO closure may reflect additional comorbid risk factors unrelated to the potential for paradoxical embolism. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 28, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Nathaniel W. Taggart, Guy S. Reeder, Ryan J. Lennon, Joshua P. Slusser, Monique A. Freund, Allison K. Cabalka, Frank Cetta, Donald J. Hagler Tags: Valvular and Structural Heart Diseases Source Type: research

Long‐term follow‐up after PFO device closure
ConclusionsDevice closure of PFO can be performed safely with very good long‐term resolution of atrial shunting. Recurrent neurologic events after PFO closure may reflect additional comorbid risk factors unrelated to the potential for paradoxical embolism. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 28, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Nathaniel W. Taggart, Guy S. Reeder, Ryan J. Lennon, Joshua P. Slusser, Monique A. Freund, Allison K. Cabalka, Frank Cetta, Donald J. Hagler Tags: Valvular and Structural Heart Diseases Source Type: research

HeartStitch touts new PFO closure method
Structural heart focused HeartStitch said today its NobleStitch EL device was used to repair 3 patients with patent forman ovale heart defects in Astana, Kazakhstan. A patent foramen ovale is a congenital heart disease in which hole in the heart that normally seals at birth remains open, and can lead to severe migraines, visual auras and stroke, the company said. The procedures were performed by Dr. Michael Mullen and guided by Anthony Nobles at the National Research Cardiac Surgery Center in Astana, according to the company. “We are gratified that our colleagues from abroad have brought this technology to Kazakhstan...
Source: Mass Device - September 11, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular HeartStitch Source Type: news

Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long‐term follow‐up of 301 cases
Patent foramen ovale has been identified as a conduit for paradoxical embolism resulting in cryptogenic stroke or transient ischemic attack (TIA). We aimed to establish rates of death, recurrent stroke or TIA among patients undergoing PFO closure for stroke or TIA at our unit. A retrospective analysis of all PFO closure patients was performed between May 2004 and January 2013. Follow up was performed by mortality tracing using the Medical Research Information Service of the Office of National Statistics. With regard to stroke or TIA recurrence, written consent forms and questionnaires were mailed with follow up telephone c...
Source: Catheterization and Cardiovascular Interventions - June 23, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Mikaeil Mirzaali, Maureen Dooley, Dylan Wynne, Nina Cooter, Lorraine Lee, Peter Haworth, Romi Saha, Nicola Gainsborough, David Hildick‐Smith Tags: Valvular and Structural Heart Diseases Source Type: research

Routine troponin measurements are unnecessary in acute ischemic stroke evaluations (P4.285)
CONCLUSIONS: Troponin elevation in patients with ischemic stroke is not caused by acute myocardial ischemia unless iatrogenic in the setting of vasopressor administration. Serum troponins should be measured based on clinical context rather than routinely in all acute ischemic stroke patients.Disclosure: Dr. Ali has nothing to disclose. Dr. Young has nothing to disclose. Dr. Rabinstein has received royalty payments from Elsevier and Oxford University Press. Dr. Rabinstein has received research support from DJO Global. Dr. Flemming has nothing to disclose. Dr. Fugate has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Ali, F., Young, J., Rabinstein, A., Flemming, K., Fugate, J. Tags: Cerebrovascular Disease and Interventional Neurology: Acute Ischemic Stroke Care Source Type: research

Initial experience with the novel patent foramen ovale occlusion device Nit‐Occlud® in patients with stroke or transient ischemic attack
ConclusionIn patients with cryptogenic stroke or TIA and a PFO, the Nit‐Occlud® PFO Occlusion Device appears to be both a safe and effective means to occlude the PFO. It is associated with high procedural success and favorable rates of complete closure. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - April 2, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Daniel H. Steinberg, Stefan C. Bertog, Julia Momberger, Jennifer Franke, Ilona Hofmann, Kristina Renkhoff, Sonya Joy, Laura Vaskelyte, Horst Sievert Tags: Valvular and Structural Heart Diseases Source Type: research

PFO closure with only fluoroscopic guidance: 7 years real‐world single centre experience
ConclusionsIn our experience Fluoro‐G PFO closure was performed mainly in cases of simple anatomy, with similar results in terms of safety and efficacy compared to Echo‐G cases. Both fluoroscopy and total procedural times were lower in the Fluo‐G cases. © 2014 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 19, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Antonio Mangieri, Cosmo Godino, Matteo Montorfano, Francesco Arioli, Isabella Rosa, Silvia Ajello, Daniela Piraino, Alberto Monello, Anna Giulia Pavon, Giacomo Viani, Valeria Magni, Alberto Cappelletti, Alberto Margonato, Antonio Colombo Tags: Pediatric and Congenital Heart Disease Source Type: research

The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale
Conclusion: No difference was found in closure or complication rates between the Flatstent and the umbrella devices. With appropriate pre‐assessment of the PFO anatomy, the Flatstent works as a safe and effective method of treating the PFO from within the tunnel, especially in those with long tunnel PFOs. Longer follow up is needed to establish superiority. This article is protected by copyright. All rights reserved.
Source: Catheterization and Cardiovascular Interventions - November 20, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Mert Aral, Michael Mullen Tags: Original Studies Source Type: research

Results of percutaneous closure of patent foramen ovale with the GORE® septal occluder
ConclusionPFO closure with the GSO is accompanied by a high technical success rate and closure rates similar to other currently used devices. The incidence of AF was higher than reported with most other devices. This may be a chance finding but warrants further investigation in larger trials. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - January 20, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Meike Knerr, Stefan Bertog, Laura Vaskelyte, Ilona Hofmann, Horst Sievert Tags: Valvular and Structural Heart Diseases Source Type: research